Association of factor VII protein concentration with lifestyle factors

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 58, Issue 4, 1998, Pages 323-330

  Bladbjerg, E M ^a   Moller L ^b   Jespersen, J ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Factor VII; Lifestyle; Population study; Thrombotic risk

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ALCOHOL CONSUMPTION; ARTICLE; BLEEDING TIME; BODY MASS; CHOLESTEROL BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN BLOOD LEVEL; LIFESTYLE; MALE; MULTIPLE REGRESSION; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; PULSE RATE; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; THROMBOSIS PREVENTION; TRIACYLGLYCEROL BLOOD LEVEL;

NICOTIANA TABACUM;

EID: 0031830073     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519850186508     Document Type: Article

References (46)

1. Meade TW, Brozovic M, Chakrabarti R, Haines AP, Imeson JD, Mellows S, et al. Haemostatic function and ischaemic heart disease: Principal results of The Northwick Park Heart Study. Lancet 1986; ii: 533-7.
2. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-9.
3. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-9.
4. Balleisen L, Bailey J, Epping PH, Schulte H, Van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, bodyweight, smoking, alcohol, pill-using, and menopause. Thromb Haemost 1985; 54: 475-9.
5. Balleisen L, Assmann G, Bailey J, Epping PH, Schulte H, Van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population - II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions. Thromb Haemost 1985; 54: 721-3.
6. Folsom AR, Qamhieh HT, Wing RR, Jeffery RW, Stinson VL, Kuller LH, Wu KK. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb 1993; 13: 162-9.
7. Fuller JH, Keen H, Jarrett RJ, Omer T, Meade TW, Chakrabarti R, North WRS, Stirling Y. Haemostatic variables associated with diabetes and its complications. Br Med J 1979; 2: 964-6.
8. Brozovic M, Stirling Y, Harricks C, North WRS, Meade TW. Factor VII in an industrial population. Br J Haematol 1974; 28: 381-91.
9. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205.
10. Dalaker K, Prydz H. The coagulation factor VII in pregnancy. Br J Haematol 1984; 56: 233-41.
11. Jern C, Eriksson E, Tengborn L, Risberg B, Wadenvik H, Jern S. Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost 1989; 62: 767-71.
12. Marckmann P, Sandström B, Jespersen J. Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb 1993; 13: 505-11.
13. Marckmann P, Sandström B, Jespersen J. Low-fat high-fiber diet favorably affects several independent risk markers of ischemic heart disease. Observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr 1994; 59: 935-9.
14. Bladbjerg EM, Marckmann P, Sandström B, Jespersen J. Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet. Thromb Haemost 1994; 71: 755-8.
15. Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 1996; 16: 72-6.
16. Seligsohn U, Østerud B, Brown SF, Griffin JH, Rapaport SI. Activation of human factor VII in plasma and purified systems. J Clin Invest 1979; 64: 1056-65.
17. Plu-Bureau G, Scarabin PY, Bara L, Malmejac A, Guize L, Samama M. Factor VII activation and oral contraceptives. Thromb Res 1993; 70: 275-80.
18. Bruckert E, Carvalho de Sousa JC, Giral P, Soria C, Chapman MJ, Caen J, de Gennes JL. Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolaemia. Atherosclerosis 1989; 75: 129-34.
19. Carvalho de Sousa J, Bruckert E, Giral P, Soria C, Truffert J, Mirshahi MC, et al. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidaemia: A clinical and laboratory study. Haemostasis 1989; 19: 83-90.
20. Carvalho de Sousa J, Bruckert E, Soria C, Caen JP. Phospholipase C sensitive factor VII activity and factor VII antigen in hypertriglyceridaemia. Nouv Rev Fr Hematol 1989; 31: 13-5.
21. Hoffman C, Shah A, Sodums M, Hultin MB. Factor VII activity state in coronary artery disease. J Lab Clin Med 1988; 111: 475-81.
22. Hoffman CJ, Miller RH, Lawson WE, Hultin MB. Elevation of factor VII activity and mass in young adults at risk of ischaemic heart disease. J Am Coll Cardiol 1989; 14: 941-6.
23. Suzuki T, Yamauchi K, Matsushita T, Furumichi T, Furui H, Tsuzuki J, Saito H. Elevation of factor VII activity and mass in coronary artery disease of varying severity. Clin Cardiol 1991; 14: 731-6.
24. Bladbjerg EM, Tholstrup T, Marckmann P, Sandström B, Jespersen J. Dietary changes in fasting levels of factor VII coagulant activity (FVII:C) are accompanied by changes in factor VII protein and other vitamin K-dependent proteins. Thromb Haemost 1995; 73: 239-42.
25. Marckmann P, Sandström B, Jespersen J. Effects of total fat content and fatty acid composition on factor VII coagulant activity and blood lipids. Atherosclerosis 1990; 80: 227-33.
26. Silveira A, Karpe F, Blombäck M, Steiner G, Walldius G, Hamsten A. Activation of coagulation factor VII during alimentary lipemia. Arterioscler Thromb 1994; 14: 60-9.
27. Salomaa V, Rasi V, Pekkanen J, Jauhiainen M. Vahtera E, Pietinen P, et al. The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity. Atherosclerosis 1993; 103: 1-11.
28. Hoffman CJ, Miller RH, Hultin MB. Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1992; 12: 267-70.
29. Hoffman CJ, Lawson WE, Miller RH, Hultin MB. Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1994; 14: 1737-40.
30. Scarabin PY, Bonithon-Kopp C, Bara L, Malmejac A, Guize L, Samama M. Factor VII activation and menopausal status. Thromb Res 1990; 57: 227-34.
31. Howard PR, Bovill EG, Pike J, Church WR, Tracy RP. Factor VII antigen levels in a healthy blood donor population. Thromb Haemost 1994; 72: 21-7.
32. Douglas AS. Anticoagulant therapy. Oxford: Blackwell Scientific, 1962: 16-8.
33. Bladbjerg EM, Overgaard K, Gram J. Jespersen J. The protein concentration of blood coagulation factor VII can be measured equally well in plasma and serum. Scand J Clin Lab Invest 1995; 55: 267-71.
34. Hollnagel H. 40-åriges helbred. Thesis. Copenhagen: University of Copenhagen, 1985
35. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. Geneva: WHO, 1982
36. Hales CN, Randle PJ. Immunoassay of insulin with insulin antibody precipitate. J Biochem 1963; 88: 137-46.
37. Astrup T, Brakman P, Nissen U. The estimation of fibrinogen. Scan J Clin Lab Invest 1965; 17: 57-65.
38. Møller L, Kristensen TS. Plasma fibrinogen and ischaemic heart disease risk factors. Arterioscler Thromb 1991; 11: 344-50.
39. Connelly JB, Cooper JA, Meade TW. Strenuous exercise, plasma fibrinogen, and factor VII activity. Br Heart J 1992; 67: 351-4.
40. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987; ii: 986-8.
41. Prisco D, Fedi S, Brunelli T, Cellai AP, Hagi MI. Gianni R, et al. Fibrinogen and factor VIIag in healthy adolescents: The Floren-teen (Florence Teenager) Study. Thromb Haemost 1996; 75: 778-81.
42. Humphries SE, Lane A, Green FR, Cooper J. Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb 1994; 14: 193-8.
43. Marongiu F, Biondi G, Sorano GG, Mameli G, Conti M, Mamusa AM, et al. Bleeding time is prolonged during oral anticoagulant therapy. Thromb Res 1990; 59: 905-12.
44. Mitropoulos KA, Esnouf MP. The prothrombin activation peptide regulates synthesis of the vitamin K-dependent proteins in the rabbit. Thromb Res 1990; 57: 541-9.
45. Carvalho de Sousa J, Soria C, Ayrault-Jarrier M, Pastier D, Bruckert E, Amiral J, Bereziat G, Caen JP. Association between coagulation factor VII and X with triglyceride rich lipoproteins. J Clin Pathol 1988; 41: 940-4.
46. Møller LF, Jespersen J. Fasting serum insulin levels and the coronary heart disease in a Danish cohort: 17-years follow-up. J Cardiovasc Risk 1995; 2: 235-40.